North America

Delegates from QIC, Pantheon and Mubadala discuss their approaches to diversity, equity and inclusion at a time when the US administration is taking a more critical view of DEI initiatives.

A key concern is that a GP may not have market-tested the highest selling price of an asset, according to the $212bn pension's senior investment officer for PE.

Apogem Capital, an investor in more than 60 GP-led secondaries, and law firm Willkie Farr & Gallagher team up to explain how lead investors and legal counsel can help investors in continuation funds feel comfortable that the sponsor is aligned with their interests.

Until July, the healthcare-focused firm’s sole partner was its founder, the former global head of healthcare private investing at Goldman Sachs

The investment into Churchill and Arcmont marks the Singapore’s sovereign wealth fund’s second such purchase in recent weeks.

The firm still believes 2025 has the potential to be a well-performing vintage year, according to its chief executive.

More capital was raised for secondaries in H1 2025 than during any other first half since the strategy’s inception.

Secondaries use is soaring as the search for liquidity intensifies.